Molecular Weight:   | 284.1 |
Volume:   | 299.545 |
LogP:   | 3.454 |
LogD:   | 3.38 |
LogS:   | -4.992 |
# Rotatable Bonds:   | 5 |
TPSA:   | 55.76 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 4 |
QED Drug-Likeness Score:   | 0.676 |
Synthetic Accessibility Score:   | 2.004 |
Fsp3:   | 0.118 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Rejected |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.851 |
MDCK Permeability:   | 1.3412893167696893e-05 |
Pgp-inhibitor:   | 0.008 |
Pgp-substrate:   | 0.025 |
Human Intestinal Absorption (HIA):   | 0.009 |
20% Bioavailability (F20%):   | 0.004 |
30% Bioavailability (F30%):   | 0.838 |
Blood-Brain-Barrier Penetration (BBB):   | 0.33 |
Plasma Protein Binding (PPB):   | 99.33106231689453% |
Volume Distribution (VD):   | 0.501 |
Pgp-substrate:   | 1.1844139099121094% |
CYP1A2-inhibitor:   | 0.986 |
CYP1A2-substrate:   | 0.856 |
CYP2C19-inhibitor:   | 0.925 |
CYP2C19-substrate:   | 0.16 |
CYP2C9-inhibitor:   | 0.815 |
CYP2C9-substrate:   | 0.953 |
CYP2D6-inhibitor:   | 0.774 |
CYP2D6-substrate:   | 0.896 |
CYP3A4-inhibitor:   | 0.871 |
CYP3A4-substrate:   | 0.264 |
Clearance (CL):   | 9.916 |
Half-life (T1/2):   | 0.486 |
hERG Blockers:   | 0.125 |
Human Hepatotoxicity (H-HT):   | 0.049 |
Drug-inuced Liver Injury (DILI):   | 0.747 |
AMES Toxicity:   | 0.352 |
Rat Oral Acute Toxicity:   | 0.042 |
Maximum Recommended Daily Dose:   | 0.383 |
Skin Sensitization:   | 0.855 |
Carcinogencity:   | 0.697 |
Eye Corrosion:   | 0.053 |
Eye Irritation:   | 0.988 |
Respiratory Toxicity:   | 0.785 |
Natural Product ID:   | NPC188646 |
Common Name*:   | Flavokawain B |
IUPAC Name:   | (E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-en-1-one |
Synonyms:   | |
Standard InCHIKey:   | QKQLSQLKXBHUSO-CMDGGOBGSA-N |
Standard InCHI:   | InChI=1S/C17H16O4/c1-20-13-10-15(19)17(16(11-13)21-2)14(18)9-8-12-6-4-3-5-7-12/h3-11,19H,1-2H3/b9-8+ |
SMILES:   | COc1cc(O)c(c(c1)OC)C(=O)/C=C/c1ccccc1 |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL104255 |
PubChem CID:   |
5356121 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO25128 | Panax vietnamensis | Species | Araliaceae | Eukaryota | n.a. | Vietnamese | n.a. |
PMID[11325227] |
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[11830162] |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | bud covers | n.a. | n.a. |
PMID[11975520] |
NPO8788 | Renealmia nicolaioides | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12444686] |
NPO18596 | Melia dubia | Species | Meliaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12502333] |
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12542368] |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | n.a. | root | n.a. |
PMID[12662107] |
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12809361] |
NPO22637 | Kunzea ambigua | Species | Myrtaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[15043420] |
NPO10407 | Petromyzon marinus | Species | Petromyzontidae | Eukaryota | n.a. | n.a. | n.a. |
PMID[15193266] |
NPO16772 | Piper rusbyi | Species | Piperaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[17354169] |
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | root | n.a. | n.a. |
PMID[25597012] |
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[28139925] |
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[31184894] |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | Fruit | n.a. | n.a. | Database[FooDB] |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | Seed | n.a. | n.a. | Database[FooDB] |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO22500 | Stephania dielsiana | Species | Menispermaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO21600 | Aconitum variegatum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO27620.1 | Pteris cretica var. nervosa | Varieties | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO24672 | Helleborus purpurascens | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO24672 | Helleborus purpurascens | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO21600 | Aconitum variegatum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO27620.1 | Pteris cretica var. nervosa | Varieties | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO22500 | Stephania dielsiana | Species | Menispermaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO21600 | Aconitum variegatum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO10407 | Petromyzon marinus | Species | Petromyzontidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8171 | Artocarpus altilis | Species | Moraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25557 | Alternaria porri | Species | Pleosporaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24866 | Smilax aspera | Species | Smilacaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24672 | Helleborus purpurascens | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26193 | Piper methysticum | Species | Piperaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO5676 | Annulohypoxylon multiforme | Species | Xylariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25410 | Manilkara bidentata | Species | Sapotaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24549 | Scutellaria cordifrons | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO27620.1 | Pteris cretica var. nervosa | Varieties | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO16772 | Piper rusbyi | Species | Piperaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO21534 | Ostrya carpinifolia | Species | Betulaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18762 | Ilex microdonta | Species | Aquifoliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24735 | Cupania latifolia | Species | Sapindaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28771 | Clematis delavayi | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24821 | Nidorella resedifolia | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO21600 | Aconitum variegatum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18950 | Cephalotaxus fortunei | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO16885 | Phonus arborescens | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO21344 | Fadogia agrestis | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18259 | Chaetanthera chilensis | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20691 | Echinocereus merkeri | Species | Cactaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18529 | Salvia broussoneti | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19082 | Creolophus cirrhatus | Species | Hericiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20584 | Cheilanthes fragrans | Species | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18596 | Melia dubia | Species | Meliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25468 | Tabernaemontana amygdalifolia | Species | Apocynaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25128 | Panax vietnamensis | Species | Araliaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19721 | Impatiens roylei | Species | Balsaminaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24591 | Trichosanthes dioica | Species | Cucurbitaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19008 | Mentha cablin | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23489 | Stachys anisochila | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22500 | Stephania dielsiana | Species | Menispermaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8788 | Renealmia nicolaioides | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22637 | Kunzea ambigua | Species | Myrtaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO17249 | Lespedeza capitata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8943 | Juniperus californica | Species | Cupressaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25321 | Acantholimon glumaceum | Species | Plumbaginaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 20000.0 | nM | PMID[568135] |
NPT111 | Cell Line | K562 | Homo sapiens | Activity | = | 28.0 | % | PMID[568136] |
NPT440 | Individual Protein | Quinone oxidoreductase | Mus musculus | CD | = | 1.7 | ug ml-1 | PMID[568137] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 25118.9 | nM | PMID[568140] |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 17782.8 | nM | PMID[568141] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 10000.0 | nM | PMID[568141] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 14125.4 | nM | PMID[568140] |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 14125.4 | nM | PMID[568140] |
NPT54 | Individual Protein | Nonstructural protein 1 | Influenza A virus | Potency | = | 11220.2 | nM | PMID[568141] |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 35481.3 | nM | PMID[568140] |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[568140] |
NPT524 | Individual Protein | Serine-protein kinase ATM | Homo sapiens | Potency | = | 28183.8 | nM | PMID[568141] |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 15848.9 | nM | PMID[568140] |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[568141] |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[568141] |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | n.a. | 14125.4 | nM | PMID[568141] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 20587.8 | nM | PMID[568141] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 14125.4 | nM | PMID[568140] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 63095.7 | nM | PMID[568141] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[568141] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 28183.8 | nM | PMID[568141] |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | n.a. | 10691.0 | nM | PMID[568141] |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[568140] |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | n.a. | 3784.43 | nM | PMID[568143] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 3288.52 | nM | PMID[568143] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 5970.35 | nM | PMID[568143] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 8729.71 | nM | PMID[568143] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 5834.45 | nM | PMID[568143] |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | n.a. | 3723.92 | nM | PMID[568143] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | n.a. | 7726.81 | nM | PMID[568143] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 1207.81 | nM | PMID[568143] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 3784.43 | nM | PMID[568143] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 9268.3 | nM | PMID[568143] |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | n.a. | 4613.18 | nM | PMID[568143] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 4425.88 | nM | PMID[568143] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 7095.78 | nM | PMID[568143] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 5370.32 | nM | PMID[568143] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 12022.64 | nM | PMID[568143] |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 3801.89 | nM | PMID[568143] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 4602.57 | nM | PMID[568143] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 3639.15 | nM | PMID[568143] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 23878.11 | nM | PMID[568143] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 7638.36 | nM | PMID[568143] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 3467.37 | nM | PMID[568143] |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | n.a. | 1849.27 | nM | PMID[568143] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 6546.36 | nM | PMID[568143] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 3845.92 | nM | PMID[568143] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 2421.03 | nM | PMID[568143] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 3515.6 | nM | PMID[568143] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 7943.28 | nM | PMID[568143] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 5164.16 | nM | PMID[568143] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 3854.78 | nM | PMID[568143] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 7998.34 | nM | PMID[568143] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 2290.87 | nM | PMID[568143] |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | n.a. | 4466.84 | nM | PMID[568143] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 4623.81 | nM | PMID[568143] |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | n.a. | 2971.67 | nM | PMID[568143] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 10327.61 | nM | PMID[568143] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 4508.17 | nM | PMID[568143] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 5636.38 | nM | PMID[568143] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 4977.37 | nM | PMID[568143] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 10399.2 | nM | PMID[568143] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | n.a. | 6095.37 | nM | PMID[568143] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | n.a. | 7798.3 | nM | PMID[568143] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 11614.49 | nM | PMID[568143] |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | n.a. | 6823.39 | nM | PMID[568143] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 3539.97 | nM | PMID[568143] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 5284.45 | nM | PMID[568143] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 4140.0 | nM | PMID[568143] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 4709.77 | nM | PMID[568143] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 13031.67 | nM | PMID[568143] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 4528.98 | nM | PMID[568143] |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | n.a. | 3198.9 | nM | PMID[568143] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 4623.81 | nM | PMID[568143] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 10789.47 | nM | PMID[568143] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 2269.86 | nM | PMID[568143] |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | n.a. | 4149.54 | nM | PMID[568143] |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | n.a. | 7655.97 | nM | PMID[568143] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 3341.95 | nM | PMID[568143] |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | n.a. | 12502.59 | nM | PMID[568143] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 14521.12 | nM | PMID[568143] |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 101.0 | % | PMID[568144] |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 191.0 | % | PMID[568144] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | Inhibition | = | 67.9 | % | PMID[568145] |
NPT1422 | Individual Protein | ATP-binding cassette sub-family G member 2 | Homo sapiens | Inhibition | = | 60.4 | % | PMID[568145] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[568141] |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[568141] |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | n.a. | 25118.9 | nM | PMID[568141] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 27.15 | % | PMID[568146] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 18356.4 | nM | PMID[568141] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 25929.0 | nM | PMID[568140] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 14581.0 | nM | PMID[568141] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[568140] |
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[568141] |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | n.a. | 19952.6 | nM | PMID[568141] |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | Survival | = | 10.0 | % | PMID[568151] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Survival | = | 1.0 | % | PMID[568151] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Survival | = | 19.0 | % | PMID[568151] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | Survival | = | 0.0 | % | PMID[568151] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Survival | = | 27.0 | % | PMID[568151] |
NPT2378 | Cell Line | NCI-H727 | Homo sapiens | Survival | = | 2.0 | % | PMID[568151] |
NPT941 | Cell Line | HaCaT | Homo sapiens | Survival | = | 7.0 | % | PMID[568151] |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | IC50 | = | 15900.0 | nM | PMID[568151] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | IC50 | = | 9900.0 | nM | PMID[568151] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 16300.0 | nM | PMID[568151] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 7500.0 | nM | PMID[568151] |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 9100.0 | nM | PMID[568151] |
NPT2378 | Cell Line | NCI-H727 | Homo sapiens | IC50 | = | 11300.0 | nM | PMID[568151] |
NPT941 | Cell Line | HaCaT | Homo sapiens | IC50 | = | 13600.0 | nM | PMID[568151] |
NPT2186 | Cell Line | RL | Homo sapiens | IC50 | = | 8200.0 | nM | PMID[568151] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 15500.0 | nM | PMID[568151] |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | Activity_index | = | 2.2 | n.a. | PMID[568151] |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | Activity | = | 55.0 | % | PMID[568151] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity_index | = | 9.7 | n.a. | PMID[568151] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity | = | 42.0 | % | PMID[568151] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity_index | = | 5.2 | n.a. | PMID[568151] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity | = | 54.0 | % | PMID[568151] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | Activity_index | = | 1.1 | n.a. | PMID[568151] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | Activity | = | 37.0 | % | PMID[568151] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity_index | = | 4.2 | n.a. | PMID[568151] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 35.0 | % | PMID[568151] |
NPT2378 | Cell Line | NCI-H727 | Homo sapiens | Activity_index | = | 0.8 | n.a. | PMID[568151] |
NPT2378 | Cell Line | NCI-H727 | Homo sapiens | Activity | = | 39.0 | % | PMID[568151] |
NPT941 | Cell Line | HaCaT | Homo sapiens | Activity_index | = | 3.4 | n.a. | PMID[568151] |
NPT941 | Cell Line | HaCaT | Homo sapiens | Activity | = | 50.0 | % | PMID[568151] |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | Activity_index | = | 1.7 | n.a. | PMID[568151] |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | Activity | = | 30.0 | % | PMID[568151] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity_index | = | 19.3 | n.a. | PMID[568151] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity | = | 40.0 | % | PMID[568151] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity_index | = | 6.8 | n.a. | PMID[568151] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Activity | = | 40.0 | % | PMID[568151] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | Activity_index | = | 0.6 | n.a. | PMID[568151] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | Activity | = | 28.0 | % | PMID[568151] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity_index | = | 2.0 | n.a. | PMID[568151] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 20.0 | % | PMID[568151] |
NPT2378 | Cell Line | NCI-H727 | Homo sapiens | Activity_index | = | 0.2 | n.a. | PMID[568151] |
NPT2378 | Cell Line | NCI-H727 | Homo sapiens | Activity | = | 7.0 | % | PMID[568151] |
NPT941 | Cell Line | HaCaT | Homo sapiens | Activity_index | = | 0.9 | n.a. | PMID[568151] |
NPT941 | Cell Line | HaCaT | Homo sapiens | Activity | = | 21.0 | % | PMID[568151] |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | > | 20000.0 | nM | PMID[568154] |
NPT466 | Cell Line | U-937 | Homo sapiens | IC50 | > | 20000.0 | nM | PMID[568154] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 19700.0 | nM | PMID[568154] |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | IC50 | = | 18200.0 | nM | PMID[568154] |
NPT2142 | Cell Line | REH | Homo sapiens | IC50 | > | 20000.0 | nM | PMID[568154] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | > | 20000.0 | nM | PMID[568154] |
NPT3213 | Individual Protein | MAP kinase signal-integrating kinase 2 | Homo sapiens | Inhibition | > | 50.0 | % | PMID[568155] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | Inhibition | = | 80.6 | % | PMID[568156] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 4200.0 | nM | PMID[568156] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | = | 26500.0 | nM | PMID[568156] |
NPT27 | Others | Unspecified | IC50 | = | 7.2 | ug.mL-1 | PMID[568137] | |
NPT2 | Others | Unspecified | IC50 | > | 20000.0 | nM | PMID[568138] | |
NPT2 | Others | Unspecified | IC50 | = | 8.0 | ug.mL-1 | PMID[568139] | |
NPT27 | Others | Unspecified | IC50 | = | 6.6 | ug.mL-1 | PMID[568139] | |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PMID[568141] | |
NPT2 | Others | Unspecified | IC50 | = | 3300.0 | nM | PMID[568142] | |
NPT27 | Others | Unspecified | Activity | < | 5.0 | % | PMID[568142] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 18526.0 | nM | PMID[568141] |
NPT2 | Others | Unspecified | Potency | n.a. | 8912.5 | nM | PMID[568141] | |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[568141] |
NPT888 | Individual Protein | 78 kDa glucose-regulated protein | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[568140] |
NPT2 | Others | Unspecified | Potency | n.a. | 14125.4 | nM | PMID[568141] | |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 4.56 | % | PMID[568146] |
NPT2 | Others | Unspecified | Potency | n.a. | 29092.9 | nM | PMID[568141] | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[568141] |
NPT22906 | PROTEIN COMPLEX | Urease subunit alpha/Urease subunit beta | Helicobacter pylori (strain ATCC 700392 / 26695) (Campylobacterpylori) | IC50 | = | 1220000.0 | nM | PMID[568147] |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 141.41 | % | PMID[568148] |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 125.2 | % | PMID[568148] |
NPT2 | Others | Unspecified | Potency | n.a. | 12589.3 | nM | PMID[568141] | |
NPT2 | Others | Unspecified | Potency | n.a. | 22387.2 | nM | PMID[568140] | |
NPT2 | Others | Unspecified | Potency | n.a. | 11220.2 | nM | PMID[568141] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 4.9 | ug.mL-1 | PMID[568149] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 7700.0 | nM | PMID[568150] |
NPT2 | Others | Unspecified | Survival | = | 32.0 | % | PMID[568151] | |
NPT2 | Others | Unspecified | IC50 | > | 20000.0 | nM | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.7 | n.a. | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.7 | n.a. | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.6 | n.a. | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 3.5 | n.a. | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.9 | n.a. | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.3 | n.a. | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.9 | n.a. | PMID[568151] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 3.2 | n.a. | PMID[568151] | |
NPT35 | Others | n.a. | LogP | = | 3.9 | n.a. | PMID[568152] | |
NPT1018 | Organism | Trypanosoma brucei | Trypanosoma brucei | EC50 | = | 6200.0 | nM | PMID[568152] |
NPT19 | Organism | Escherichia coli | Escherichia coli | Inhibition | = | 2.45 | % | PMID[568153] |
NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | = | 12.32 | % | PMID[568153] |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | = | 10.96 | % | PMID[568153] |
NPT2922 | Organism | Staphylococcus aureus subsp. aureus | Staphylococcus aureus subsp. aureus | Inhibition | = | 9.23 | % | PMID[568153] |
NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | = | 7.33 | % | PMID[568153] |
NPT20 | Organism | Candida albicans | Candida albicans | Inhibition | = | 6.59 | % | PMID[568153] |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | Inhibition | = | -7.74 | % | PMID[568153] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC188646 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC263670 |
1.0 | High Similarity | NPC56031 |
1.0 | High Similarity | NPC175098 |
1.0 | High Similarity | NPC242294 |
1.0 | High Similarity | NPC337373 |
1.0 | High Similarity | NPC139813 |
1.0 | High Similarity | NPC312318 |
1.0 | High Similarity | NPC472365 |
1.0 | High Similarity | NPC192304 |
0.9922 | High Similarity | NPC286336 |
0.9921 | High Similarity | NPC257756 |
0.9921 | High Similarity | NPC212631 |
0.9921 | High Similarity | NPC205468 |
0.9921 | High Similarity | NPC87231 |
0.9921 | High Similarity | NPC129132 |
0.9844 | High Similarity | NPC18877 |
0.9844 | High Similarity | NPC20560 |
0.9844 | High Similarity | NPC159623 |
0.9844 | High Similarity | NPC144051 |
0.9844 | High Similarity | NPC28753 |
0.9844 | High Similarity | NPC294593 |
0.9844 | High Similarity | NPC204960 |
0.9844 | High Similarity | NPC82225 |
0.9843 | High Similarity | NPC64359 |
0.9843 | High Similarity | NPC308037 |
0.9843 | High Similarity | NPC262359 |
0.9769 | High Similarity | NPC168105 |
0.9769 | High Similarity | NPC477242 |
0.9769 | High Similarity | NPC66349 |
0.9769 | High Similarity | NPC472367 |
0.9769 | High Similarity | NPC476333 |
0.9769 | High Similarity | NPC473391 |
0.9769 | High Similarity | NPC98115 |
0.9769 | High Similarity | NPC472364 |
0.9769 | High Similarity | NPC150399 |
0.9769 | High Similarity | NPC249606 |
0.9769 | High Similarity | NPC12165 |
0.9769 | High Similarity | NPC186838 |
0.9769 | High Similarity | NPC41461 |
0.9769 | High Similarity | NPC25287 |
0.9769 | High Similarity | NPC477243 |
0.9769 | High Similarity | NPC1486 |
0.9769 | High Similarity | NPC274109 |
0.9769 | High Similarity | NPC477244 |
0.9695 | High Similarity | NPC472419 |
0.9695 | High Similarity | NPC153979 |
0.9695 | High Similarity | NPC188879 |
0.9695 | High Similarity | NPC317119 |
0.9692 | High Similarity | NPC131039 |
0.9692 | High Similarity | NPC13575 |
0.9692 | High Similarity | NPC156092 |
0.9688 | High Similarity | NPC475008 |
0.9688 | High Similarity | NPC309717 |
0.9688 | High Similarity | NPC186097 |
0.9688 | High Similarity | NPC128348 |
0.9688 | High Similarity | NPC313618 |
0.9688 | High Similarity | NPC66384 |
0.9688 | High Similarity | NPC112192 |
0.9688 | High Similarity | NPC164236 |
0.9688 | High Similarity | NPC189106 |
0.9688 | High Similarity | NPC475009 |
0.9685 | High Similarity | NPC247779 |
0.9621 | High Similarity | NPC21350 |
0.9621 | High Similarity | NPC124269 |
0.9621 | High Similarity | NPC472368 |
0.9618 | High Similarity | NPC240593 |
0.9618 | High Similarity | NPC213603 |
0.9615 | High Similarity | NPC103842 |
0.9606 | High Similarity | NPC211120 |
0.9549 | High Similarity | NPC470211 |
0.9549 | High Similarity | NPC472366 |
0.9549 | High Similarity | NPC477956 |
0.9545 | High Similarity | NPC266597 |
0.9545 | High Similarity | NPC116632 |
0.9545 | High Similarity | NPC303644 |
0.9545 | High Similarity | NPC162680 |
0.9545 | High Similarity | NPC7013 |
0.9545 | High Similarity | NPC209560 |
0.9545 | High Similarity | NPC250266 |
0.9545 | High Similarity | NPC181124 |
0.9545 | High Similarity | NPC294409 |
0.9538 | High Similarity | NPC27643 |
0.9528 | High Similarity | NPC80694 |
0.9528 | High Similarity | NPC186098 |
0.9478 | High Similarity | NPC172250 |
0.9478 | High Similarity | NPC215311 |
0.9478 | High Similarity | NPC213659 |
0.9478 | High Similarity | NPC48624 |
0.9478 | High Similarity | NPC11056 |
0.9478 | High Similarity | NPC259166 |
0.9478 | High Similarity | NPC219917 |
0.9478 | High Similarity | NPC326109 |
0.9478 | High Similarity | NPC204985 |
0.9478 | High Similarity | NPC144118 |
0.9478 | High Similarity | NPC80962 |
0.9474 | High Similarity | NPC471620 |
0.9474 | High Similarity | NPC90665 |
0.9474 | High Similarity | NPC251681 |
0.9474 | High Similarity | NPC279668 |
0.9474 | High Similarity | NPC278323 |
0.9474 | High Similarity | NPC99333 |
0.9474 | High Similarity | NPC309154 |
0.9474 | High Similarity | NPC243528 |
0.9474 | High Similarity | NPC55162 |
0.9474 | High Similarity | NPC12175 |
0.9474 | High Similarity | NPC188947 |
0.9474 | High Similarity | NPC280284 |
0.947 | High Similarity | NPC473887 |
0.947 | High Similarity | NPC231772 |
0.947 | High Similarity | NPC29353 |
0.947 | High Similarity | NPC124784 |
0.947 | High Similarity | NPC127447 |
0.947 | High Similarity | NPC13408 |
0.947 | High Similarity | NPC194281 |
0.947 | High Similarity | NPC234133 |
0.947 | High Similarity | NPC47815 |
0.9449 | High Similarity | NPC305518 |
0.9449 | High Similarity | NPC128428 |
0.9407 | High Similarity | NPC55832 |
0.9407 | High Similarity | NPC26051 |
0.9407 | High Similarity | NPC268204 |
0.9407 | High Similarity | NPC469404 |
0.9407 | High Similarity | NPC470087 |
0.9407 | High Similarity | NPC470089 |
0.9407 | High Similarity | NPC321980 |
0.9407 | High Similarity | NPC52789 |
0.9407 | High Similarity | NPC110969 |
0.9407 | High Similarity | NPC49108 |
0.9403 | High Similarity | NPC109232 |
0.9403 | High Similarity | NPC283429 |
0.9403 | High Similarity | NPC295384 |
0.9398 | High Similarity | NPC290291 |
0.9398 | High Similarity | NPC275055 |
0.9394 | High Similarity | NPC39426 |
0.9394 | High Similarity | NPC234560 |
0.938 | High Similarity | NPC185497 |
0.9338 | High Similarity | NPC11561 |
0.9338 | High Similarity | NPC471417 |
0.9338 | High Similarity | NPC119663 |
0.9338 | High Similarity | NPC226636 |
0.9333 | High Similarity | NPC129853 |
0.9333 | High Similarity | NPC253822 |
0.9333 | High Similarity | NPC188243 |
0.9333 | High Similarity | NPC110228 |
0.9333 | High Similarity | NPC6407 |
0.9333 | High Similarity | NPC76445 |
0.9333 | High Similarity | NPC159275 |
0.9333 | High Similarity | NPC69769 |
0.9333 | High Similarity | NPC269652 |
0.9333 | High Similarity | NPC172986 |
0.9333 | High Similarity | NPC270883 |
0.9333 | High Similarity | NPC241100 |
0.9333 | High Similarity | NPC101366 |
0.9333 | High Similarity | NPC265178 |
0.9333 | High Similarity | NPC284550 |
0.9333 | High Similarity | NPC281207 |
0.9333 | High Similarity | NPC261227 |
0.9323 | High Similarity | NPC24394 |
0.9323 | High Similarity | NPC87545 |
0.9323 | High Similarity | NPC235428 |
0.9318 | High Similarity | NPC172262 |
0.9318 | High Similarity | NPC164136 |
0.9313 | High Similarity | NPC15834 |
0.9313 | High Similarity | NPC203817 |
0.9313 | High Similarity | NPC215875 |
0.9313 | High Similarity | NPC10971 |
0.9302 | High Similarity | NPC69235 |
0.9302 | High Similarity | NPC212379 |
0.9302 | High Similarity | NPC60558 |
0.9291 | High Similarity | NPC65041 |
0.927 | High Similarity | NPC149026 |
0.927 | High Similarity | NPC18585 |
0.927 | High Similarity | NPC475705 |
0.927 | High Similarity | NPC117836 |
0.927 | High Similarity | NPC301751 |
0.927 | High Similarity | NPC166138 |
0.927 | High Similarity | NPC175504 |
0.927 | High Similarity | NPC91560 |
0.927 | High Similarity | NPC39329 |
0.927 | High Similarity | NPC75049 |
0.927 | High Similarity | NPC106985 |
0.927 | High Similarity | NPC143896 |
0.927 | High Similarity | NPC257097 |
0.927 | High Similarity | NPC245482 |
0.927 | High Similarity | NPC169591 |
0.927 | High Similarity | NPC51887 |
0.927 | High Similarity | NPC68104 |
0.927 | High Similarity | NPC150408 |
0.927 | High Similarity | NPC310130 |
0.927 | High Similarity | NPC164980 |
0.927 | High Similarity | NPC476178 |
0.927 | High Similarity | NPC221432 |
0.9265 | High Similarity | NPC126534 |
0.9265 | High Similarity | NPC90582 |
0.9265 | High Similarity | NPC3188 |
0.9265 | High Similarity | NPC262094 |
0.9265 | High Similarity | NPC147688 |
0.9265 | High Similarity | NPC232021 |
0.9265 | High Similarity | NPC64908 |
0.9265 | High Similarity | NPC26238 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC188646 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9688 | High Similarity | NPD1240 | Approved |
0.9538 | High Similarity | NPD1607 | Approved |
0.9394 | High Similarity | NPD1510 | Phase 2 |
0.9185 | High Similarity | NPD1549 | Phase 2 |
0.9111 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9111 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9065 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8929 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8897 | High Similarity | NPD2796 | Approved |
0.8857 | High Similarity | NPD6799 | Approved |
0.875 | High Similarity | NPD4380 | Phase 2 |
0.869 | High Similarity | NPD7411 | Suspended |
0.8633 | High Similarity | NPD970 | Clinical (unspecified phase) |
0.8592 | High Similarity | NPD1511 | Approved |
0.8581 | High Similarity | NPD3882 | Suspended |
0.8571 | High Similarity | NPD2801 | Approved |
0.8571 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.854 | High Similarity | NPD6651 | Approved |
0.8523 | High Similarity | NPD7075 | Discontinued |
0.8519 | High Similarity | NPD6859 | Clinical (unspecified phase) |
0.8514 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8511 | High Similarity | NPD1878 | Clinical (unspecified phase) |
0.8503 | High Similarity | NPD1934 | Approved |
0.8493 | Intermediate Similarity | NPD6599 | Discontinued |
0.8489 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8489 | Intermediate Similarity | NPD2935 | Discontinued |
0.8472 | Intermediate Similarity | NPD1512 | Approved |
0.8446 | Intermediate Similarity | NPD7819 | Suspended |
0.8446 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.84 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.838 | Intermediate Similarity | NPD3750 | Approved |
0.8378 | Intermediate Similarity | NPD6801 | Discontinued |
0.831 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8284 | Intermediate Similarity | NPD1203 | Approved |
0.8261 | Intermediate Similarity | NPD943 | Approved |
0.8212 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8194 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8182 | Intermediate Similarity | NPD2800 | Approved |
0.8182 | Intermediate Similarity | NPD2654 | Approved |
0.8169 | Intermediate Similarity | NPD2344 | Approved |
0.8163 | Intermediate Similarity | NPD5403 | Approved |
0.8158 | Intermediate Similarity | NPD3749 | Approved |
0.8146 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8102 | Intermediate Similarity | NPD6832 | Phase 2 |
0.8088 | Intermediate Similarity | NPD2798 | Approved |
0.8077 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8077 | Intermediate Similarity | NPD9493 | Approved |
0.8065 | Intermediate Similarity | NPD6232 | Discontinued |
0.806 | Intermediate Similarity | NPD3972 | Approved |
0.806 | Intermediate Similarity | NPD9717 | Approved |
0.8056 | Intermediate Similarity | NPD1243 | Approved |
0.8028 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.8028 | Intermediate Similarity | NPD3748 | Approved |
0.8028 | Intermediate Similarity | NPD2799 | Discontinued |
0.8027 | Intermediate Similarity | NPD5401 | Approved |
0.8027 | Intermediate Similarity | NPD2532 | Approved |
0.8027 | Intermediate Similarity | NPD2534 | Approved |
0.8027 | Intermediate Similarity | NPD2533 | Approved |
0.8025 | Intermediate Similarity | NPD7473 | Discontinued |
0.8 | Intermediate Similarity | NPD6959 | Discontinued |
0.7975 | Intermediate Similarity | NPD3818 | Discontinued |
0.7955 | Intermediate Similarity | NPD9545 | Approved |
0.7945 | Intermediate Similarity | NPD2309 | Approved |
0.7937 | Intermediate Similarity | NPD5953 | Discontinued |
0.7925 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7925 | Intermediate Similarity | NPD7054 | Approved |
0.7925 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7919 | Intermediate Similarity | NPD920 | Approved |
0.7891 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7875 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7875 | Intermediate Similarity | NPD7472 | Approved |
0.7857 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD422 | Phase 1 |
0.7852 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7826 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7821 | Intermediate Similarity | NPD5494 | Approved |
0.782 | Intermediate Similarity | NPD1548 | Phase 1 |
0.78 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7792 | Intermediate Similarity | NPD5402 | Approved |
0.7785 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD7251 | Discontinued |
0.773 | Intermediate Similarity | NPD7808 | Phase 3 |
0.773 | Intermediate Similarity | NPD3268 | Approved |
0.773 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD2313 | Discontinued |
0.7724 | Intermediate Similarity | NPD6100 | Approved |
0.7724 | Intermediate Similarity | NPD6099 | Approved |
0.7718 | Intermediate Similarity | NPD7390 | Discontinued |
0.7714 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7692 | Intermediate Similarity | NPD230 | Phase 1 |
0.7673 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7669 | Intermediate Similarity | NPD6559 | Discontinued |
0.7655 | Intermediate Similarity | NPD7033 | Discontinued |
0.7655 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7626 | Intermediate Similarity | NPD2797 | Approved |
0.7622 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7591 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7582 | Intermediate Similarity | NPD3226 | Approved |
0.7576 | Intermediate Similarity | NPD1241 | Discontinued |
0.7569 | Intermediate Similarity | NPD1933 | Approved |
0.7569 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7554 | Intermediate Similarity | NPD3225 | Approved |
0.7554 | Intermediate Similarity | NPD1876 | Approved |
0.7534 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7532 | Intermediate Similarity | NPD919 | Approved |
0.7517 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1470 | Approved |
0.75 | Intermediate Similarity | NPD1164 | Approved |
0.7485 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7483 | Intermediate Similarity | NPD3764 | Approved |
0.7483 | Intermediate Similarity | NPD411 | Approved |
0.7482 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD7458 | Discontinued |
0.7464 | Intermediate Similarity | NPD1201 | Approved |
0.7462 | Intermediate Similarity | NPD9266 | Approved |
0.7462 | Intermediate Similarity | NPD74 | Approved |
0.7448 | Intermediate Similarity | NPD447 | Suspended |
0.7447 | Intermediate Similarity | NPD1019 | Discontinued |
0.7439 | Intermediate Similarity | NPD1729 | Discontinued |
0.7438 | Intermediate Similarity | NPD1247 | Approved |
0.7432 | Intermediate Similarity | NPD2346 | Discontinued |
0.7413 | Intermediate Similarity | NPD3027 | Phase 3 |
0.741 | Intermediate Similarity | NPD1608 | Approved |
0.74 | Intermediate Similarity | NPD7003 | Approved |
0.7394 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD9494 | Approved |
0.7391 | Intermediate Similarity | NPD5711 | Approved |
0.7391 | Intermediate Similarity | NPD5710 | Approved |
0.7389 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7385 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7385 | Intermediate Similarity | NPD9263 | Approved |
0.7385 | Intermediate Similarity | NPD9264 | Approved |
0.7385 | Intermediate Similarity | NPD9267 | Approved |
0.7376 | Intermediate Similarity | NPD3267 | Approved |
0.7376 | Intermediate Similarity | NPD3266 | Approved |
0.7372 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD5408 | Approved |
0.7365 | Intermediate Similarity | NPD5404 | Approved |
0.7365 | Intermediate Similarity | NPD5405 | Approved |
0.7365 | Intermediate Similarity | NPD5406 | Approved |
0.7361 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7349 | Intermediate Similarity | NPD6104 | Discontinued |
0.7342 | Intermediate Similarity | NPD4288 | Approved |
0.7342 | Intermediate Similarity | NPD2296 | Approved |
0.7299 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7286 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7283 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7283 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7279 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD846 | Approved |
0.7266 | Intermediate Similarity | NPD940 | Approved |
0.7266 | Intermediate Similarity | NPD3847 | Discontinued |
0.7261 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD3140 | Approved |
0.726 | Intermediate Similarity | NPD4307 | Phase 2 |
0.726 | Intermediate Similarity | NPD3142 | Approved |
0.7241 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7241 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD6798 | Discontinued |
0.7237 | Intermediate Similarity | NPD2354 | Approved |
0.7226 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7222 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7214 | Intermediate Similarity | NPD1535 | Discovery |
0.7211 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7211 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD4662 | Approved |
0.7208 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD4661 | Approved |
0.72 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7195 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7194 | Intermediate Similarity | NPD17 | Approved |
0.7174 | Intermediate Similarity | NPD1894 | Discontinued |
0.7172 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7168 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7163 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7153 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7153 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD4287 | Approved |
0.7143 | Intermediate Similarity | NPD6971 | Discontinued |
0.7143 | Intermediate Similarity | NPD1613 | Approved |
0.7143 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4357 | Discontinued |
0.7132 | Intermediate Similarity | NPD9281 | Approved |
0.7124 | Intermediate Similarity | NPD3887 | Approved |
0.7122 | Intermediate Similarity | NPD9268 | Approved |
0.7122 | Intermediate Similarity | NPD1651 | Approved |
0.7113 | Intermediate Similarity | NPD4749 | Approved |
0.7108 | Intermediate Similarity | NPD3751 | Discontinued |
0.7107 | Intermediate Similarity | NPD6844 | Discontinued |
0.7107 | Intermediate Similarity | NPD6280 | Approved |
0.7107 | Intermediate Similarity | NPD6279 | Approved |
0.7103 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7095 | Intermediate Similarity | NPD6355 | Discontinued |
0.7091 | Intermediate Similarity | NPD2403 | Approved |
0.7086 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.